Recruiting Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas NCT03356782 Conditions Bone Diseases, Bone Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +12 more Locations Shenzhen Geno-immune Medical Institute — Shenzhen, Guangdong, China View Trial Details
Recruiting Combination Immunotherapy Targeting Sarcomas NCT04433221 Conditions Bone Diseases, Bone Neoplasms, Ewing Sarcoma, +11 more Locations Shenzhen Geno-Immune Medical Institute — Shenzhen, Guangdong, China View Trial Details
